1.A Selective Mutism Arising from First Language Attrition, Successfully Treated with Paroxetine-CBT Combination Treatment.
Agostino SERRA ; Paola DI MAURO ; Claudio ANDALORO ; Luigi MAIOLINO ; Piero PAVONE ; Salvatore COCUZZA
Psychiatry Investigation 2015;12(4):569-572
After immersion in a foreign language, speakers often have difficulty retrieving native-language words and may experience a decrease in its proficiency, this phenomenon, in the non-pathological form, is known as first language attrition. Self-perception of this low native-language proficiency and apprehension occurring when speaking is expected and, may sometimes lead these people to a state of social anxiety and, in extreme forms, can involve the withholding of speech as a primitive tool for self-protection, linking them to selective mutism. We report an unusual case of selective mutism arising from first language attrition in an Italian girl after attending a two-year "German language school", who successfully responded to a paroxetine-cognitive behavioral treatment (CBT) combination treatment.
Anxiety
;
Cognitive Therapy
;
Female
;
Humans
;
Immersion
;
Mutism*
;
Paroxetine
;
Self Concept
4.The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates alpha-thrombin activity: potential clinical implications.
Marilena LEPRETTI ; Susan COSTANTINI ; Gaetano AMMIRATO ; Gaia GIUBERTI ; Michele CARAGLIA ; Angelo M FACCHIANO ; Salvatore METAFORA ; Paola STIUSO
Experimental & Molecular Medicine 2008;40(5):541-549
We have previously shown that seminal vesicle protein IV (SV-IV) and its 1-70 N-terminal fragment have anti-inflammatory activity and modulate anti-thrombin III (AT) activity. Moreover, mass spectrometry analysis of purified SV-IV has shown that the protein was found to be highly heterogeneous and 14% of the total SV-IV molecules are truncated forms, of particular interest the 1-16, 1-17, and 1-18 peptides. In this work we report experimental data which demonstrate that the 1-16 peptide (P1-16) possesses a marked effect on the AT activity by preventing the formation of the thrombin-AT complex. We found that the formation of thrombin-AT complex is markedly decreased in the presence of P1-16 used at equimolar concentration with thrombin as evaluated with SDS-PAGE. We also monitored the conformational changes of thrombin in the presence of different P1-16 concentrations, and calculated the K(d) of thrombin/P1-16 system by circular dichroism technique. The probable interaction sites of P1-16 with thrombin have been also evaluated by molecular graphics and computational analyses. These results have potential implications in the treatment of sterility and thrombotic diseases.
Amino Acid Sequence
;
Animals
;
Antithrombin III/metabolism
;
Blood Coagulation/drug effects
;
Circular Dichroism
;
Humans
;
Models, Molecular
;
Molecular Sequence Data
;
Peptide Fragments/*chemistry/pharmacology
;
Protein Binding/drug effects
;
Protein Structure, Secondary
;
Protein Structure, Tertiary
;
Rats
;
Seminal Vesicle Secretory Proteins/*chemistry/genetics/metabolism
;
Thrombin/*chemistry/genetics/metabolism
5.Prevalence of Non-erosive Esophageal Phenotypes in Children: A European Multicenter Study
Elisa BLASI ; Ettore STEFANELLI ; Renato TAMBUCCI ; Silvia SALVATORE ; Paola De ANGELIS ; Paolo QUITADAMO ; Claudia PACCHIAROTTI ; Giovanni Di NARDO ; Fanj CROCCO ; Enrico FELICI ; Valentina GIORGIO ; Nicoletta STAROPOLI ; Simona SESTITO ; Efstratios SALIAKELLIS ; Osvaldo BORRELLI ; Licia PENSABENE
Journal of Neurogastroenterology and Motility 2023;29(2):156-165
Background/Aims:
Since available data on pediatric non-erosive esophageal phenotypes (NEEPs) are scant, we investigated their prevalence and the phenotype-dependent treatment response in these children.
Methods:
Over a 5-year period, children with negative upper endoscopy, who underwent esophageal pH-impedance (off-therapy) for persisting symptoms not responsive to proton pump inhibitor (PPI)-treatment, were recruited. Based on the results of acid reflux index (RI) and symptom association probability (SAP), patients were categorized into: (1) abnormal RI (non-erosive reflux disease [NERD]), (2) normal RI and abnormal SAP (reflux hypersensitivity [RH]), (3) normal RI and normal SAP (functional heartburn [FH]), and (4) normal RI and not-reliable SAP (normal-RI-not otherwise-specified [normal-RI-NOS]). For each subgroup, treatment response was evaluated.
Results:
Out of 2333 children who underwent esophageal pH-impedance, 68 cases, including 18 NERD, 14 RH, 26 FH, and 10 normal-RI-NOS were identified as fulfilling the inclusion criteria and were analyzed. Considering symptoms before endoscopy, chest pain was more reported in NERD than in other cases (6/18 vs 5/50, P = 0.031). At long-term follow-up of 23 patients (8 NERD, 8 FH, 2 RH, and 5 normal-RI-NOS): 17 were on PPIs and 2 combined alginate, 1 (FH) was on benzodiazepine + anticholinergic, 1 (normal-RI-NOS) on citalopram, and 3 had no therapy. A complete symptom-resolution was observed in 5/8 NERD, in 2/8 FH, and in 2/5 normal-RI-NOS.
Conclusions
FH may be the most common pediatric NEEP. At long-term follow-up, there was a trend toward a more frequent complete symptom resolution with PPI-therapy in NERD patients while other groups did not benefit from extended acid-suppressive-treatment.